niacin 250 MG Extended Release Oral Tablet [Endur-Acin]
RxNorm concept 2001472, branded drug (sbd). Prescribable name: ENDUR-ACIN 250 MG Extended Release Oral Tablet.
- RxCUI
- 2001472
- Term type
- Branded drug (SBD)
- Status
- Active
curl https://api.healthcare.dev/v1/drugs/rxnorm/2001472 \ -H "Authorization: Bearer $HDEV_API_KEY"
Concept
Ingredients and related concepts
Ingredients
Other names
Endur-Acin 250 MG Extended Release Oral Tablet; nicotinic acid 250 MG Extended Release Oral Tablet [Endur-Acin]; vit-B3 250 MG Extended Release Oral Tablet [Endur-Acin]; vitamin B3 250 MG Extended Release Oral Tablet [Endur-Acin]
Related concepts
- niacin 250 MG (SCDC, consists of)
- niacin 250 MG [Endur-Acin] (SBDC, consists of)
- Extended Release Oral Tablet (DF, has dose form)
- Endur-Acin (BN, has ingredient)
- niacin 250 MG Extended Release Oral Tablet (SCD, tradename of)
Linked data
NDCs
- 29135012102
NDC-11s RxNorm links to this concept; linked ones open their FDA product.
Use it
Look up 2001472 from code or an agent
curl https://api.healthcare.dev/v1/drugs/rxnorm/2001472 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up RxNorm concept 2001472. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.
Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.